CTLA4 and neoplasm: To understand the functional relationship between anti-tumor efficacy and irAEs mediated by ICB, we leveraged a rapid autopsy approach to gather multiple tissue samples from a single patient with advanced melanoma who experienced both tumor regression and irAEs during treatment with anti-PD-1 and anti-CTLA-4.